Abbott Laboratories Stock Forecast for 2022 - 2025 - 2030

Updated on 09/26/2022

Stock Rating
14
Price Target
$126.00
Consensus
Outperform
Upside
26.20%
Analysts
19
Stock Rating
14
Upside
26.20%
Analysts
19
Price Target
$126.00

Abbott Laboratories Stock Forecast and Price Target

Abbott Laboratories's stock price reaches the average target of $126.00 by 2023 as expected recently by nineteen notable experts, there would be a potential upside of approximately 26.2% from the last closing price in September, 2022. This possible increase is based on a high estimate of $150.00 and a low estimate of $95.00. If you are interested in ABT stock, it is important to also consider its competitors.

$126.00

26.20% Upside

Outperform
Outperform

Abbott Laboratories Fair Value Forecast for 2022 - 2025 - 2030

In the last three years, Abbott Laboratories's Price has grown by 80.90%, rising from $75.77 to $137.08. For the following year, the 22 analysts predict that Abbott Laboratories's Fair Value will drop by 6.72%, reaching $127.87. Over the next nine years, experts predict that Abbott Laboratories's Fair Value will grow at a rate of 76.59%.

2022 Fair Value Forecast
$127.87
2023 Fair Value Forecast
$131.55
2024 Fair Value Forecast
$145.49
2025 Fair Value Forecast
$160.49
2026 Fair Value Forecast
$174.96
2027 Fair Value Forecast
$190.82
2028 Fair Value Forecast
$207.31
2029 Fair Value Forecast
$224.26
2030 Fair Value Forecast
$242.06
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$307.50 Buy/Sell $333.19 13.82%
DHR Stock Forecast Danaher Outperform 16
$262.66 Buy/Sell $321.60 23.73%
AZN Stock Forecast AstraZeneca PLC Outperform 18
£99.33 Buy/Sell £136.08 43.33%
CSL Stock Forecast CSL Outperform 16
$284.81 Buy/Sell $228.01 -22.67%
AMAT Stock Forecast Applied Materials Outperform 10
$82.94 Buy/Sell $135.22 50.71%

Abbott Laboratories Revenue Forecast for 2022 - 2025 - 2030

In the last three years, Abbott Laboratories's Revenue has grown by 40.87%, rising from $30.58B to $43.08B. For the following year, the 20 analysts predict that Abbott Laboratories's Revenue will drop by 3.35%, reaching $41.63B. Over the next nine years, experts predict that Abbott Laboratories's Revenue will grow at a rate of 43.62%.

2022 Rev Forecast
$41.63B
2023 Rev Forecast
$41.39B
2024 Rev Forecast
$44.20B
2025 Rev Forecast
$46.58B
2026 Rev Forecast
$49.65B
2027 Rev Forecast
$52.57B
2028 Rev Forecast
$55.53B
2029 Rev Forecast
$58.68B
2030 Rev Forecast
$61.87B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BDX Stock Forecast Becton, Dickinson and Outperform 17
$231.64 Buy/Sell $278.08 20.88%
MMM Stock Forecast 3M Hold 16
$113.00 Buy/Sell $147.79 21.24%
CL Stock Forecast Colgate-Palmolive Outperform 18
$75.00 Buy/Sell $82.26 9.33%

Abbott Laboratories Dividend per Share Forecast for 2022 - 2025 - 2030

In the last three years, Abbott Laboratories's Dividend per Share has grown, rising from $1.16 to $1.82 – a growth of 56.90%. In the following year, the 10 analysts surveyed believe that Abbott Laboratories's Dividend per Share will decrease by 0.55%, reaching $1.81. For the next nine years, the forecast is for Dividend per Share to grow by 128.26%.

2022 DPS Forecast
$1.81
2023 DPS Forecast
$1.96
2024 DPS Forecast
$2.11
2025 DPS Forecast
$2.53
2026 DPS Forecast
$2.78
2027 DPS Forecast
$3.08
2028 DPS Forecast
$3.45
2029 DPS Forecast
$3.78
2030 DPS Forecast
$4.15
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GSK Stock Forecast GSK Outperform 16
£13.25 Buy/Sell £16.08 43.02%
BSX Stock Forecast Boston Scientific Buy 15
$38.36 Buy/Sell $49.85 25.13%
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.00k Buy/Sell ¥0.00 17.65%

Abbott Laboratories Free Cash Flow Forecast for 2022 - 2025 - 2030

Abbott Laboratories's Free Cash Flow has seen impressive growth In the last three years, rising from $4.91B to $8.65B – a growth of 76.27%. In the next year, analysts believe that Free Cash Flow will reach $9.29B – an increase of 7.42%. For the next nine years, the forecast is for Free Cash Flow to grow by 24.85%.

2022 FCF Forecast
$9.29B
2023 FCF Forecast
$8.56B
2024 FCF Forecast
$9.04B
2025 FCF Forecast
$9.48B
2026 FCF Forecast
$9.58B
2027 FCF Forecast
$9.93B
2028 FCF Forecast
$10.23B
2029 FCF Forecast
$10.49B
2030 FCF Forecast
$10.80B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
EW Stock Forecast Edwards Lifesciences Outperform 15
$83.59 Buy/Sell $127.85 41.76%
GIS Stock Forecast General Mills Hold 16
$78.66 Buy/Sell $76.67 -2.11%
BAYN Stock Forecast Bayer Outperform 7
48.37€ Buy/Sell 67.79€ 64.36%

Abbott Laboratories Net Income Forecast for 2022 - 2025 - 2030

Abbott Laboratories's Net Income has grown In the last three years, rising from $2.37B to $7.07B – a growth of 198.61%. In the next year, analysts believe that Net Income will reach $8.64B – an increase of 22.21%. For the next nine years, experts predict that Abbott Laboratories's Net Income will grow at a rate of 131.06%.

2022 NI Forecast
$8.64B
2023 NI Forecast
$8.79B
2024 NI Forecast
$9.75B
2025 NI Forecast
$10.69B
2026 NI Forecast
$11.74B
2027 NI Forecast
$12.82B
2028 NI Forecast
$13.94B
2029 NI Forecast
$15.12B
2030 NI Forecast
$16.34B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
EDF Stock Forecast Electricité de France Outperform 17
11.89€ Buy/Sell 14.68€ 0.93%
A Stock Forecast Agilent Technologies Outperform 17
$122.31 Buy/Sell $149.56 22.64%
DXCM Stock Forecast DexCom Buy 16
$80.35 Buy/Sell $120.89 24.46%

Abbott Laboratories EBITDA Forecast for 2022 - 2025 - 2030

In the last three years, Abbott Laboratories's EBITDA has grown by 79.26%, rising from $7.12B to $12.76B. For the next year, 8 analysts project Abbott Laboratories's EBITDA to drop by 5.94%, reaching $12.00B. Over the next nine years, experts believe that Abbott Laboratories's EBITDA will grow at a rate of 43.22%.

2022 EBITDA Forecast
$12.00B
2023 EBITDA Forecast
$11.94B
2024 EBITDA Forecast
$13.15B
2025 EBITDA Forecast
$12.29B
2026 EBITDA Forecast
$13.49B
2027 EBITDA Forecast
$14.61B
2028 EBITDA Forecast
$15.76B
2029 EBITDA Forecast
$17.01B
2030 EBITDA Forecast
$18.27B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BN Stock Forecast Danone Hold 18
48.61€ Buy/Sell 62.59€ 19.32%
BAX Stock Forecast Baxter International Outperform 17
$54.91 Buy/Sell $69.92 25.66%
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.89k Buy/Sell ¥0.00 27.05%

Abbott Laboratories EBIT Forecast for 2022 - 2025 - 2030

In the last three years, Abbott Laboratories's EBIT has grown, moving from $3.84B to $9.22B – an increase of 140.18%. In the next year, analysts predict that EBIT will jump to $10.33B – up 12.07% from the current level. Looking ahead to nine years, experts forecast that EBIT will grow by 112.71%.

2022 EBIT Forecast
$10.33B
2023 EBIT Forecast
$10.32B
2024 EBIT Forecast
$11.31B
2025 EBIT Forecast
$12.07B
2026 EBIT Forecast
$13.81B
2027 EBIT Forecast
$15.08B
2028 EBIT Forecast
$16.45B
2029 EBIT Forecast
$18.06B
2030 EBIT Forecast
$19.61B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
7751 Stock Forecast Canon Hold 18
¥3.20k Buy/Sell ¥0.00 4.65%
CHD Stock Forecast Church & Dwight Hold 11
$75.26 Buy/Sell $90.41 18.39%
CAH Stock Forecast Cardinal Health Hold 13
$65.77 Buy/Sell $58.69 3.39%

Abbott Laboratories EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, Abbott Laboratories's EPS has grown by 80.90%, rising from $2.88 to $5.21. For the following year, the 22 analysts predict that Abbott Laboratories's EPS will drop by 6.72%, reaching $4.86. Over the next nine years, experts predict that Abbott Laboratories's EPS will grow at a rate of 76.59%.

2022 EPS Forecast
$4.86
2023 EPS Forecast
$5.00
2024 EPS Forecast
$5.53
2025 EPS Forecast
$6.10
2026 EPS Forecast
$6.65
2027 EPS Forecast
$7.25
2028 EPS Forecast
$7.88
2029 EPS Forecast
$8.52
2030 EPS Forecast
$9.20
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIO Stock Forecast Bio-Rad Laboratories Buy 16
$414.52 Buy/Sell $701.33 68.87%
TECH Stock Forecast Bio-Techne Outperform 16
$290.08 Buy/Sell $485.91 65.47%
4523 Stock Forecast Eisai Hold 18
¥5.73k Buy/Sell ¥0.00 15.12%